121 related articles for article (PubMed ID: 28921427)
1. Human Cells as Platform to Produce Gamma-Carboxylated Proteins.
de Sousa Bomfim A; de Freitas MCC; Covas DT; de Sousa Russo EM
Methods Mol Biol; 2018; 1674():49-61. PubMed ID: 28921427
[TBL] [Abstract][Full Text] [Related]
2. Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide.
Camire RM; Larson PJ; Stafford DW; High KA
Biochemistry; 2000 Nov; 39(46):14322-9. PubMed ID: 11087381
[TBL] [Abstract][Full Text] [Related]
3. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle.
Wajih N; Hutson SM; Owen J; Wallin R
J Biol Chem; 2005 Sep; 280(36):31603-7. PubMed ID: 16030016
[TBL] [Abstract][Full Text] [Related]
4. Hepatic vitamin K-dependent carboxylation of blood-clotting proteins.
Liebman HA; Furie BC; Furie B
Hepatology; 1982; 2(4):488-94. PubMed ID: 7095749
[No Abstract] [Full Text] [Related]
5. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme.
Vatandoost J; Zomorodipour A; Sadeghizadeh M; Aliyari R; Bos MH; Ataei F
Biotechnol Prog; 2012; 28(1):45-51. PubMed ID: 22012919
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequence homology and the vitamin K-dependent proteins.
Hewett-Emmett D
Bibl Haematol; 1977; 44():94-104. PubMed ID: 367360
[TBL] [Abstract][Full Text] [Related]
7. Plasma PIVKA proteins in rabbits given warfarin.
Zivelin A; Rao LV; Rapaport SI
Thromb Res; 1996 Jun; 82(5):429-38. PubMed ID: 8771703
[TBL] [Abstract][Full Text] [Related]
8. Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: implications for the release of vitamin K-dependent proteins.
Hallgren KW; Hommema EL; McNally BA; Berkner KL
Biochemistry; 2002 Dec; 41(50):15045-55. PubMed ID: 12475254
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mode of action of vitamin K.
Olson RE
Adv Enzyme Regul; 1966; 4():181-96. PubMed ID: 4168681
[No Abstract] [Full Text] [Related]
10. Differential effects of warfarin on the intracellular processing of vitamin K-dependent proteins.
Wu W; Bancroft JD; Suttie JW
Thromb Haemost; 1996 Jul; 76(1):46-52. PubMed ID: 8819250
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
Zivelin A; Rao LV; Rapaport SI
J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
[TBL] [Abstract][Full Text] [Related]
12. The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX.
Blostein M; Cuerquis J; Landry S; Galipeau J
Haemophilia; 2008 Sep; 14(5):1063-8. PubMed ID: 18680528
[TBL] [Abstract][Full Text] [Related]
13. Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection.
Wajih N; Owen J; Wallin R
Thromb Res; 2008; 122(3):405-10. PubMed ID: 18177690
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.
Takahashi H; Hanano M; Hayashi S; Arai Y; Yoshino N; Takakuwa E; Tatewaki W; Nagayama R; Takizawa S; Shibata A
Tohoku J Exp Med; 1986 Aug; 149(4):351-7. PubMed ID: 3775760
[TBL] [Abstract][Full Text] [Related]
15. Warfarin therapy. 1.
Deykin D
N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
[No Abstract] [Full Text] [Related]
16. Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.
Berkner KL
Methods Enzymol; 1993; 222():450-77. PubMed ID: 8412810
[No Abstract] [Full Text] [Related]
17. Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.
Annis DS; Ma H; Balas DM; Kumfer KT; Sandbo N; Potts GK; Coon JJ; Mosher DF
PLoS One; 2015; 10(8):e0135374. PubMed ID: 26273833
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
Walz DA; Kipfer RK; Olson RE
J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
[TBL] [Abstract][Full Text] [Related]
19. Activation of clotting factors in prothrombin complex concentrates as demonstrated by clotting assays for factors IXa and Xa.
Elödi S; Váradi K
Thromb Res; 1978 May; 12(5):797-807. PubMed ID: 675589
[No Abstract] [Full Text] [Related]
20. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
Suzuki K
Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
